TSHA
Taysha Gene Therapies Inc
NASDAQ · Biotechnology
$4.61
+0.20 (+4.54%)
Open$4.60
Previous Close$4.41
Day High$4.70
Day Low$4.44
52W High$6.02
52W Low$1.05
Volume—
Avg Volume2.32M
Market Cap1.26B
P/E Ratio—
EPS$-0.33
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+1,220.2% upside
Current
$4.61
$4.61
Target
$60.86
$60.86
$45.99
$60.86 avg
$68.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.12M | 249.41M | 242.81M |
| Net Income | -97,789,215 | 43.60M | 41.01M |
| Profit Margin | -1,071.6% | 17.5% | 16.9% |
| EBITDA | -103,925,009 | 65.17M | 60.77M |
| Free Cash Flow | — | 41.80M | 46.40M |
| Rev Growth | — | +22.8% | -6.9% |
| Debt/Equity | 0.63 | 0.76 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |